BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20346033)

  • 21. Role of Geriatric Oncologists in Optimizing Care of Urological Oncology Patients.
    Droz JP; Boyle H; Albrand G; Mottet N; Puts M
    Eur Urol Focus; 2017 Oct; 3(4-5):385-394. PubMed ID: 29128297
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Screening for prostate cancer: the current evidence and guidelines controversy.
    Gomella LG; Liu XS; Trabulsi EJ; Kelly WK; Myers R; Showalter T; Dicker A; Wender R
    Can J Urol; 2011 Oct; 18(5):5875-83. PubMed ID: 22018148
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of Metastatic Prostate Cancer in Older Adults.
    Loh KP; Mohile SG; Kessler E; Fung C
    Curr Oncol Rep; 2016 Oct; 18(10):63. PubMed ID: 27586377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening for prostate cancer.
    Ilic D; Neuberger MM; Djulbegovic M; Dahm P
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD004720. PubMed ID: 23440794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Undertreatment of Men in Their Seventies with High-risk Nonmetastatic Prostate Cancer.
    Bratt O; Folkvaljon Y; Hjälm Eriksson M; Akre O; Carlsson S; Drevin L; Franck Lissbrant I; Makarov D; Loeb S; Stattin P
    Eur Urol; 2015 Jul; 68(1):53-8. PubMed ID: 25813688
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toward the realization of a better aged society: messages from gerontology and geriatrics.
    Arai H; Ouchi Y; Yokode M; Ito H; Uematsu H; Eto F; Oshima S; Ota K; Saito Y; Sasaki H; Tsubota K; Fukuyama H; Honda Y; Iguchi A; Toba K; Hosoi T; Kita T;
    Geriatr Gerontol Int; 2012 Jan; 12(1):16-22. PubMed ID: 22188494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate cancer screening in men 75 years old or older: an assessment of self-reported health status and life expectancy.
    Hoffman KE; Nguyen PL; Ng AK; D'Amico AV
    J Urol; 2010 May; 183(5):1798-802. PubMed ID: 20299039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aged patients with metastatic castration resistant prostate cancer: Should we treat with chemotherapy?
    Climent MÁ; Torregrosa MD; Vázquez S; Gironés R; Arranz JA
    Cancer Treat Rev; 2017 Apr; 55():173-180. PubMed ID: 28411479
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer. Review.
    Molina-Garrido MJ; Guillén-Ponce C
    Aging Male; 2017 Jun; 20(2):102-109. PubMed ID: 28084133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A national survey of radiation oncologists and urologists on recommendations of prostate-specific antigen screening for prostate cancer.
    Kim SP; Karnes RJ; Nguyen PL; Ziegenfuss JY; Thompson RH; Han LC; Shah ND; Smaldone MC; Gross CP; Frank I; Weight CJ; Beebe TJ; Tilburt JC
    BJU Int; 2014 May; 113(5b):E106-11. PubMed ID: 24053213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Re: management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.
    Griebling TL
    J Urol; 2011 Feb; 185(2):520. PubMed ID: 22088633
    [No Abstract]   [Full Text] [Related]  

  • 33. The critical role of the pathologist in determining eligibility for active surveillance as a management option in patients with prostate cancer: consensus statement with recommendations supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation.
    Amin MB; Lin DW; Gore JL; Srigley JR; Samaratunga H; Egevad L; Rubin M; Nacey J; Carter HB; Klotz L; Sandler H; Zietman AL; Holden S; Montironi R; Humphrey PA; Evans AJ; Epstein JI; Delahunt B; McKenney JK; Berney D; Wheeler TM; Chinnaiyan AM; True L; Knudsen B; Hammond ME
    Arch Pathol Lab Med; 2014 Oct; 138(10):1387-405. PubMed ID: 25092589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early detection of prostate cancer: European Association of Urology recommendation.
    Heidenreich A; Abrahamsson PA; Artibani W; Catto J; Montorsi F; Van Poppel H; Wirth M; Mottet N;
    Eur Urol; 2013 Sep; 64(3):347-54. PubMed ID: 23856038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
    Lam TBL; MacLennan S; Willemse PM; Mason MD; Plass K; Shepherd R; Baanders R; Bangma CH; Bjartell A; Bossi A; Briers E; Briganti A; Buddingh KT; Catto JWF; Colecchia M; Cox BW; Cumberbatch MG; Davies J; Davis NF; De Santis M; Dell'Oglio P; Deschamps A; Donaldson JF; Egawa S; Fankhauser CD; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Gross T; Grummet JP; Henry AM; Ingels A; Irani J; Lardas M; Liew M; Lin DW; Moris L; Omar MI; Pang KH; Paterson CC; Renard-Penna R; Ribal MJ; Roobol MJ; Rouprêt M; Rouvière O; Sancho Pardo G; Richenberg J; Schoots IG; Sedelaar JPM; Stricker P; Tilki D; Vahr Lauridsen S; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; van Leenders GJLH; Varma M; Violette PD; Wallis CJD; Wiegel T; Wilkinson K; Zattoni F; N'Dow JMO; Van Poppel H; Cornford P; Mottet N
    Eur Urol; 2019 Dec; 76(6):790-813. PubMed ID: 31587989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toward the development of a vibrant, super-aged society: The future of medicine and society in Japan.
    Iijima K; Arai H; Akishita M; Endo T; Ogasawara K; Kashihara N; Hayashi YK; Yumura W; Yokode M; Ouchi Y
    Geriatr Gerontol Int; 2021 Aug; 21(8):601-613. PubMed ID: 34212470
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Health technology assessment and implications for clinical practice: the case of prostate cancer screening.
    Norderhaug IN; Sandberg S; Fosså SD; Forland F; Malde K; Kvinnsland S; Traaholt I; Rossiné BK; Førde OH
    Scand J Clin Lab Invest; 2003; 63(5):331-8. PubMed ID: 14599155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy.
    Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM
    J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.
    Heidenreich A; Bastian PJ; Bellmunt J; Bolla M; Joniau S; van der Kwast T; Mason M; Matveev V; Wiegel T; Zattoni F; Mottet N;
    Eur Urol; 2014 Jan; 65(1):124-37. PubMed ID: 24207135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. American Cancer Society guideline for the early detection of prostate cancer: update 2010.
    Wolf AM; Wender RC; Etzioni RB; Thompson IM; D'Amico AV; Volk RJ; Brooks DD; Dash C; Guessous I; Andrews K; DeSantis C; Smith RA;
    CA Cancer J Clin; 2010; 60(2):70-98. PubMed ID: 20200110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.